{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:02:40Z","timestamp":1790222560043,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T00:00:00Z","timestamp":1379116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T00:00:00Z","timestamp":1379116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recent data suggested an interaction between plasma constituents and the endothelial glycocalyx to be relevant for vascular barrier function. This might be negatively influenced by infusion solutions, depending on ionic composition, pH and binding properties. The present study evaluated such an influence of current artificial preparations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Isolated guinea pig hearts were prepared in a modified Langendorff mode and perfused with Krebs-Henseleit buffer augmented with 1g% human albumin. After equilibration the perfusion was switched to replacement of one half buffer by either isotonic saline (NaCl), ringer's acetate (Ri-Ac), 6% and 10% hydroxyethyl starch (6% and 10% HES, resp.), or 4% gelatine (Gel), the artificial colloids having been prepared in balanced solution. We analysed glycocalyx shedding, functional integrity of the vascular barrier and heart performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      While glycocalyx shedding was not observed, diluting albumin concentration towards 0.5g% by artificial solutions was associated with a marked functional breakdown of vascular barrier competence. This effect was biggest with isotonic saline and significantly attenuated with artificial colloids, the difference in the pressure dependent transvascular fluid filtration (basal vs. during infusion in groups NaCl, Ri-Ac, 6% HES, 10% HES and Gel,\n                      <jats:italic>n<\/jats:italic>\n                      = 6 each) being 0.31 \u00b1 0.03 vs. 1.00 \u00b1 0.04; 0.27 \u00b1 0.03 vs. 0.81 \u00b1 0.03; 0.29 \u00b1 0.03 vs. 0.68 \u00b1 0.02; 0.32 \u00b1 0.03 vs. 0.59 \u00b1 0.08 and 0.31 \u00b1 0.04 vs. 0.61 \u00b1 0.03 g\/5min, respectively. Heart performance was directly related to pH value (7.38 \u00b1 0.06, 7.33 \u00b1 0.03, 7.14 \u00b1 0.04, 7.08 \u00b1 0.04, 7.25 \u00b1 0.03), the change in the rate pressure product being 21,702 \u00b1 1969 vs. 21,291 \u00b1 2,552; 22,098 \u00b1 2,115 vs. 14,114 \u00b1 3,386; 20,897 \u00b1 2,083 vs. 10,671 \u00b1 1,948; 21,822 \u00b1 2,470 vs. 10,047 \u00b1 2,320 and 20,955 \u00b1 2,296 vs. 15,951 \u00b1 2,755 mmHg \u00d7 bpm, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>It appears important to maintain the pH value within a physiological range to maintain optimal myocardial contractility. Using colloids prepared in calcium-containing, balanced solutions for volume replacement therapy may attenuate the breakdown of vascular barrier competence in the critically ill.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/cc12898","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T10:18:13Z","timestamp":1379153893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The impact of crystalloidal and colloidal infusion preparations on coronary vascular integrity, interstitial oedema and cardiac performance in isolated hearts"],"prefix":"10.1186","volume":"17","author":[{"given":"York A","family":"Zausig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard F","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Potschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Nixdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Bitzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,14]]},"reference":[{"key":"2091_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1113\/jphysiol.1896.sp000596","volume":"19","author":"E Starling","year":"1896","unstructured":"Starling E: On the absorption of fluid from the connective tissue spaces.\n                           J Physiol (Lond) 1896, 19: 312-326.","journal-title":"J Physiol (Lond)"},{"key":"2091_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1113\/jphysiol.2003.058255","volume":"557","author":"RH Adamson","year":"2004","unstructured":"Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE: Oncotic pressures opposing filtration across non-fenestrated rat microvessels.\n                           J Physiol 2004, 557: 889-907. 10.1113\/jphysiol.2003.058255","journal-title":"J Physiol"},{"key":"2091_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/00000542-200405000-00025","volume":"100","author":"M Rehm","year":"2004","unstructured":"Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M, Becker BF: Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed.\n                           Anesthesiology 2004, 100: 1211-1223. 10.1097\/00000542-200405000-00025","journal-title":"Anesthesiology"},{"key":"2091_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cardiores.2006.11.021","volume":"73","author":"M Jacob","year":"2007","unstructured":"Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels.\n                           Cardiovasc Res 2007, 73: 575-586. 10.1016\/j.cardiores.2006.11.021","journal-title":"Cardiovasc Res"},{"key":"2091_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00395-010-0118-z","volume":"105","author":"BF Becker","year":"2010","unstructured":"Becker BF, Chappell D, Jacob M: Endothelial glycocalyx and coronary vascular permeability: the fringe benefit.\n                           Basic Res Cardiol 2010, 105: 687-701.","journal-title":"Basic Res Cardiol"},{"key":"2091_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/cvr\/cvq137","volume":"87","author":"BF Becker","year":"2010","unstructured":"Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M: Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential.\n                           Cardiovasc Res 2010, 87: 300-310. 10.1093\/cvr\/cvq137","journal-title":"Cardiovasc Res"},{"key":"2091_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev.bioeng.9.060906.151959","volume":"9","author":"S Weinbaum","year":"2007","unstructured":"Weinbaum S, Tarbell JM, Damiano ER: The structure and function of the endothelial glycocalyx layer.\n                           Annu Rev Biomed Eng 2007, 9: 121-167. 10.1146\/annurev.bioeng.9.060906.151959","journal-title":"Annu Rev Biomed Eng"},{"key":"2091_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/00000542-200606000-00018","volume":"104","author":"M Jacob","year":"2006","unstructured":"Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF: Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability.\n                           Anesthesiology 2006, 104: 1223-1231. 10.1097\/00000542-200606000-00018","journal-title":"Anesthesiology"},{"key":"2091_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/cvr\/cvp097","volume":"83","author":"D Chappell","year":"2009","unstructured":"Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF: Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia\/reperfusion.\n                           Cardiovasc Res 2009, 83: 388-396. 10.1093\/cvr\/cvp097","journal-title":"Cardiovasc Res"},{"key":"2091_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/SHK.0b013e3181cdc363","volume":"34","author":"D Chappell","year":"2010","unstructured":"Chappell D, Doerfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF: Glycocalyx protection reduces leukocyte adhesion following ischemia\/reperfusion.\n                           Shock 2010, 34: 133-139. 10.1097\/SHK.0b013e3181cdc363","journal-title":"Shock"},{"key":"2091_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/TP.0b013e31819c83b5","volume":"87","author":"M Jacob","year":"2009","unstructured":"Jacob M, Paul O, Mehringer L, Chappell D, Rehm M, Welsch U, Kaczmarek I, Conzen P, Becker BF: Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia.\n                           Transplantation 2009, 87: 956-965. 10.1097\/TP.0b013e31819c83b5","journal-title":"Transplantation"},{"key":"2091_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s004240050336","volume":"433","author":"S Zahler","year":"1997","unstructured":"Zahler S, Kupatt C, Seligmann C, Kowalski C, Becker BF, Gerlach E: Retention of leucocytes in reperfused, isolated hearts does not cause haemodynamically relevant permanent capillary plugging.\n                           Pflugers Arch 1997, 433: 713-720. 10.1007\/s004240050336","journal-title":"Pflugers Arch"},{"key":"2091_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/BC.2008.005","volume":"389","author":"D Chappell","year":"2008","unstructured":"Chappell D, Jacob M, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx.\n                           Biol Chem 2008, 389: 79-82.","journal-title":"Biol Chem"},{"key":"2091_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1213\/ane.0b013e3181af7fb3","volume":"109","author":"YA Zausig","year":"2009","unstructured":"Zausig YA, Zink W, Keil M, Sinner B, Barwing J, Wiese CH, Graf BM: Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest.\n                           Anesth Analg 2009, 109: 1323-1326. 10.1213\/ane.0b013e3181af7fb3","journal-title":"Anesth Analg"},{"key":"2091_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.\n                           Behav Res Methods 2007, 39: 175-191. 10.3758\/BF03193146","journal-title":"Behav Res Methods"},{"key":"2091_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/SLA.0b013e31825074f5","volume":"255","author":"AD Shaw","year":"2012","unstructured":"Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA: Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte.\n                           Ann Surg 2012, 255: 821-829. 10.1097\/SLA.0b013e31825074f5","journal-title":"Ann Surg"},{"key":"2091_CR17","doi-asserted-by":"crossref","first-page":"C967","DOI":"10.1152\/ajpcell.1990.258.6.C967","volume":"258","author":"CH Orchard","year":"1990","unstructured":"Orchard CH, Kentish JC: Effects of changes of pH on the contractile function of cardiac muscle.\n                           Am J Physiol 1990, 258: C967-C981.","journal-title":"Am J Physiol"},{"key":"2091_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1113\/jphysiol.1978.sp012231","volume":"276","author":"A Fabiato","year":"1978","unstructured":"Fabiato A, Fabiato F: Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles.\n                           J Physiol 1978, 276: 233-255.","journal-title":"J Physiol"},{"key":"2091_CR19","first-page":"H1481","volume":"261","author":"HZ Zhou","year":"1991","unstructured":"Zhou HZ, Malhotra D, Shapiro JI: Contractile dysfunction during metabolic acidosis: role of impaired energy metabolism.\n                           Am J Physiol 1991, 261: H1481-H1486.","journal-title":"Am J Physiol"},{"key":"2091_CR20","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.bcp.2005.03.010","volume":"69","author":"JA Coles Jr","year":"2005","unstructured":"Coles JA Jr, Sigg DC, Iaizzo PA: The potential benefits of 1.5% hetastarch as a cardioplegia additive.\n                           Biochem Pharmacol 2005, 69: 1553-1558. 10.1016\/j.bcp.2005.03.010","journal-title":"Biochem Pharmacol"},{"key":"2091_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000320955","volume":"86","author":"O Dagtekin","year":"2010","unstructured":"Dagtekin O, Klisa MA, Gerbershagen HJ, Marcus H, Krep H, Teschendorf P, Fischer JH: Effects of hydroxyethyl starch, gelatin and dextran on endothelium-derived relaxation in porcine coronary arteries.\n                           Pharmacology 2010, 86: 267-272. 10.1159\/000320955","journal-title":"Pharmacology"},{"key":"2091_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1006\/phrs.1999.0653","volume":"41","author":"FJ Sutherland","year":"2000","unstructured":"Sutherland FJ, Hearse DJ: The isolated blood and perfusion fluid perfused heart.\n                           Pharmacol Res 2000, 41: 613-627. 10.1006\/phrs.1999.0653","journal-title":"Pharmacol Res"},{"key":"2091_CR23","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/01.RES.72.6.1276","volume":"72","author":"A Koller","year":"1993","unstructured":"Koller A, Sun D, Kaley G: Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro.\n                           Circ Res 1993, 72: 1276-1284. 10.1161\/01.RES.72.6.1276","journal-title":"Circ Res"},{"key":"2091_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000169373","volume":"56","author":"DE Gregg","year":"1971","unstructured":"Gregg DE: Relationship between coronary flow and metabolic changes.\n                           Cardiology 1971, 56: 291-301. 10.1159\/000169373","journal-title":"Cardiology"},{"key":"2091_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1056-8719(99)00018-0","volume":"41","author":"BK Podesser","year":"1999","unstructured":"Podesser BK, Hallstrom S, Schima H, Huber L, Weisser J, Kroner A, Furst W, Wolner E: The erythrocyte-perfused \"working heart\" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts.\n                           J Pharmacol Toxicol Methods 1999, 41: 9-15. 10.1016\/S1056-8719(99)00018-0","journal-title":"J Pharmacol Toxicol Methods"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc12898.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc12898\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc12898.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T09:05:26Z","timestamp":1728291926000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc12898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,14]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,10]]}},"alternative-id":["2091"],"URL":"https:\/\/doi.org\/10.1186\/cc12898","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,14]]},"assertion":[{"value":"2 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R203"}}